Cargando…
Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial
BACKGROUND: Development of new tuberculosis (TB) drugs and alternative treatment strategies are urgently required to control the global spread of TB. Previous results have shown that vitamin D(3) (vitD(3)) and 4-phenyl butyrate (PBA) are potent inducers of the host defense peptide LL-37 that possess...
Autores principales: | Mily, Akhirunnesa, Rekha, Rokeya Sultana, Kamal, S. M. Mostafa, Arifuzzaman, Abu Saleh Mohammad, Rahim, Zeaur, Khan, Lamia, Haq, Md. Ahsanul, Zaman, Khaliqu, Bergman, Peter, Brighenti, Susanna, Gudmundsson, Gudmundur H., Agerberth, Birgitta, Raqib, Rubhana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578887/ https://www.ncbi.nlm.nih.gov/pubmed/26394045 http://dx.doi.org/10.1371/journal.pone.0138340 |
Ejemplares similares
-
Oral intake of phenylbutyrate with or without vitamin D(3) upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosis
por: Mily, Akhirunnesa, et al.
Publicado: (2013) -
Immune responses in the treatment of drug-sensitive pulmonary tuberculosis with phenylbutyrate and vitamin D(3) as host directed therapy
por: Rekha, Rokeya Sultana, et al.
Publicado: (2018) -
Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial
por: Raqib, Rubhana, et al.
Publicado: (2012) -
Phenylbutyrate Counteracts Shigella Mediated Downregulation of Cathelicidin in Rabbit Lung and Intestinal Epithelia: A Potential Therapeutic Strategy
por: Sarker, Protim, et al.
Publicado: (2011) -
Host Directed Therapy Against Infection by Boosting Innate Immunity
por: Bergman, Peter, et al.
Publicado: (2020)